APG Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,069
Closed -$211K 961
2021
Q4
$211K Buy
5,069
+500
+11% +$30K ﹤0.01% 909
2021
Q3
$286K Buy
4,569
+1,169
+34% +$84.5K ﹤0.01% 889
2021
Q2
$241K Buy
+3,400
New +$224K ﹤0.01% 892

Other funds holding NBP

APG Asset Management's NBP Position: Q1 2022 in Review

APG Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 5,069 shares — an estimated $211K sold.

APG Asset Management first reported a position in NBP in Q2 2021 and held it in 3 quarters. The position peaked at $286K in Q3 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • APG Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • APG Asset Management sold 5,069 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $211K.
  • APG Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • APG Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $286K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on APG Asset Management's 13F filing for Q1 2022, filed 12 May 2022.